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Abstract We previously reported the association of a novel
Np95/ICBP90-like RING ¢nger protein (NIRF) with a novel
PEST-containing nuclear protein (PCNP). NIRF is a nuclear
protein with a ubiquitin-like domain, a PHD ¢nger, a YDG/
SRA domain, Rb-binding motifs and a RING ¢nger. In this
study, we showed that NIRF has auto-ubiquitination activity,
the hallmark of a ubiquitin ligase. PCNP was readily ubiquiti-
nated in 293 and COS-7 cells, and NIRF ubiquitinated PCNP
in vitro as well as in vivo. Considering that NIRF is implicated
in cell cycle regulation, these ¢ndings suggest that NIRF and
PCNP are a ubiquitin ligase and its substrate, respectively, and
may constitute a novel signaling pathway with some relation to
cell proliferation.
6 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Ubiquitin-dependent protein degradation regulates various
cellular processes, including cell cycle progression, DNA re-
pair, di¡erentiation and protein transport [1^3]. Ubiquitin li-
gases confer substrate speci¢city on the proteins to be de-
graded and contribute to the e⁄ciency of ubiquitination
reactions [4]. PEST sequences, which are rich in proline (P),
glutamic acid (E), serine (S) and threonine (T), are found in a
number of short-lived proteins, such as transcription factors
and cell cycle-associated proteins. The function of those PEST
proteins is generally controlled by proteolysis, mostly via
ubiquitin-mediated degradation [5].
We previously found a novel PEST-containing nuclear pro-
tein (PCNP), and then identi¢ed a novel Np95/ICBP90-like
RING ¢nger protein (NIRF) as a protein that interacts with
PCNP [6]. NIRF possesses a characteristic domain con¢gura-
tion (a ubiquitin-like domain, a PHD ¢nger, a YDG/SRA
domain, and a RING ¢nger) shared with Np95/ICBP90, cell
proliferation-associated proteins [7,8]. NIRF and Np95/
ICBP90 are homologous to each other and belong to a novel
family of nuclear proteins [9], which we refer to as the NIRF
family. Recent evidence shows that this family is involved in
cell cycle regulation [6^10] and genome stability [11].
In this study, we investigated the function of NIRF and the
functional relationship between NIRF and PCNP.
2. Materials and methods
2.1. Materials
Ubiquitin-activating enzyme (E1) from rabbit, and ubiquitin-con-
jugating enzymes (E2s, UbcH5a and UbcH7) were purchased from
Boston Biochem (Cambridge, MA, USA), and histidine-tagged ubiq-
uitin from Sigma (St. Louis, MO, USA). MG-132 was obtained from
the Peptide Institute (Osaka, Japan). Antibodies used were the follow-
ing: anti-His monoclonal antibody (HIS-1) and anti-FLAG monoclo-
nal antibody (M2) from Sigma; anti-ubiquitin monoclonal antibody
(Ubi-1) from Zymed (San Francisco, CA, USA); anti-myc monoclo-
nal antibody (9E10) from Santa Cruz (Santa Cruz, CA, USA); anti-
HA polyclonal antibody from MBL (Nagoya, Japan); a⁄nity-puri¢ed
anti-PCNP antibody [6]; a⁄nity-puri¢ed goat anti-rabbit IgG alkaline
phosphatase conjugate (Zymed); and a⁄nity-puri¢ed anti-mouse IgG
alkaline phosphatase conjugate (Bio-Rad, Hercules, CA, USA).
2.2. Plasmids
The coding sequence of PCNP (GenBank accession number
AB037675) was cloned into the vectors pFLAG-CMV-2 (Sigma)
and pCAGGS [12]. The coding sequence of NIRF (GenBank acces-
sion number AB071698) was cloned into p3UFLAG-CMV-10 (Sig-
ma), pCMV-Myc, pCMV-HA (Clontech, Palo Alto, CA, USA), and
pCAGGS. A cDNA for ubiquitin was ampli¢ed by polymerase chain
reaction from a human brain cDNA library (Clontech) and cloned
into p3UFLAG-CMV-10 and pCMV-Myc.
2.3. Cell culture, transfection, and immunoprecipitation
COS-7 and HEK 293 cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium (Sigma) supplemented with 10% fetal calf serum (In-
vitrogen, Carlsbad, CA, USA). Transfection of the plasmids into
COS-7 or 293 cells was carried out using the E¡ectene reagent (Qia-
gen, Valencia, CA, USA) as recommended by the manufacturer. For
transfection, total DNA amount was adjusted to 1 Wg per 60 mm dish.
Medium was changed once at 24 h after transfection, and cells were
further cultured for 12 h with or without MG-132.
For immunoprecipitation, cell extracts were prepared as follows: at
36 h after transfection, cells were harvested and lysed in 1 ml per dish
of ice cold lysis bu¡er (50 mM Tris^HCl, pH 7.4, 150 mM NaCl,
5 mM EDTA, 0.5% NP-40, and a protease inhibitor cocktail [Sigma])
for 30 min, followed by centrifugation at 14 000Ug for 15 min. Pro-
tein concentrations of the extracts were estimated by a BCA protein
assay kit (Pierce, Rockford, IL, USA), and extracts with an equivalent
protein amount were used for immunoprecipitation.
Immunoprecipitation of FLAG-tagged proteins was performed with
FLAG-tagged protein immunoprecipitation kit (Sigma) according to
the manufacturer’s recommendation. Brie£y, 30 Wl of anti-FLAG M2
a⁄nity gel was added to 1 ml of cell extract, and the sample was
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shaken for 2 h in ice bath. After washing three times with washing
bu¡er (50 mM Tris^HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.1%
NP-40) and once with phosphate-bu¡ered saline, FLAG fusion pro-
tein was eluted by the use of 50 Wl of 3UFLAG peptide solution (150
ng/Wl). The eluted proteins were dissolved in Laemmli’s sample bu¡er
[13], and then subjected to sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) followed by Western blot analysis.
For immunoprecipitation of PCNP, 1 ml of extract was incubated
with 3 Wl (15 Wg) of a⁄nity-puri¢ed anti-PCNP antibody [6]. After the
sample was shaken with 30 Wl of protein A-Sepharose CL-4B gel
(Amersham, Uppsala, Sweden) for 2 h at 0‡C, immunoprecipitates
bound on the gel were dissolved with SDS^PAGE sample bu¡er
and subjected to SDS^PAGE, followed by Western blotting. The con-
centrations of the antibodies used for the Western blotting were 0.5
Wg/ml (anti-FLAG), 1 Wg/ml (anti-ubiquitin), 1 Wg/ml (anti-His), 0.1
Wg/ml (anti-myc), 2.5 Wg/ml (anti-PCNP), 1:2000 dilution (anti-HA),
1:3000 dilution (anti-mouse IgG alkaline phosphatase conjugate), and
1:3000 dilution (anti-rabbit IgG alkaline phosphatase conjugate). The
blot was reacted with CDP-Star reagent (Amersham) and the image
was captured with a Light Capture System (ATTO, Tokyo, Japan).
2.4. In vitro ubiquitination assay
FLAG-NIRF was puri¢ed from extracts of COS-7 cells transfected
with p3UFLAG-NIRF by immunoprecipitation. The ubiquitination
reaction was carried out for 60 min at 37‡C. The complete reaction
system consisted of the reaction bu¡er (25 mM HEPES pH 7.4, 10
mM NaCl, 3 mM MgCl2, 0.05% Triton X-100, 0.5 mM dithiothreitol,
3 mM ATP, 10 Wg of histidine-tagged ubiquitin), 200 ng of E1, 200 ng
of E2 (UbcH5a or UbcH7), 500 ng of FLAG-NIRF, in a ¢nal volume
of 50 Wl.
For in vitro PCNP ubiquitination assay, 1 Wg of the puri¢ed re-
combinant PCNP [6] was included in the reaction mixture. After
completion of the ubiquitination reaction, the mixture was incubated
with nickel-charged beads (Chelating Sepharose, Amersham) for 20
min at 0‡C, followed by washing three times with the ubiquitination
reaction bu¡er containing 0.5 M NaCl. Proteins conjugated with the
histidine-tagged ubiquitin were eluted with the bu¡er containing 0.5
M imidazole, and subjected to SDS^PAGE followed by Western blot
analysis with anti-PCNP or anti-His antibody.
3. Results
3.1. NIRF is a novel ubiquitin ligase
NIRF possesses a ubiquitin-like domain and a RING ¢nger
(Fig. 1), which are the functional motifs for the interaction
with a proteasome [14] and the ubiquitin ligase activity, re-
spectively [15]. The presence of both domains is similar to
Parkin, an RBR protein with a ubiquitin ligase activity [16].
Although Parkin does not contain the PHD ¢nger and the
YDG/SRA domain, this similarity suggests that NIRF could
also be a ubiquitin ligase. To test this, we transfected FLAG-
NIRF into 293 cells with or without treatment with MG-132,
a proteasome inhibitor [17], and then cell extracts were sub-
jected to immunoprecipitation with anti-FLAG antibody fol-
lowed by Western blot analysis (Fig. 2A). FLAG-NIRF mi-
grated to an Mr value of 113 kDa nearly equal to that of
untagged NIRF expressed from pCAGGS-NIRF (data not
shown). This apparent molecular size is markedly larger
than a predicted MW of 90 kDa calculated from the amino
acid composition, suggesting that NIRF may be subject to
certain modi¢cations in vivo. When the blot was immuno-
stained with anti-ubiquitin antibody, the NIRF immunopre-
cipitated from the MG-132-treated cells exhibited an intense
smearing signal resulting from ubiquitin conjugation, while
the signal was barely visible without MG-132 (Fig. 2A, right).
These results suggest that NIRF could be ubiquitinated in
vivo and subsequently subjected to rapid degradation in the
absence of proteasome inhibitor. On the other hand, a FLAG-
NIRF increase was not apparent in the presence of MG-132
(Fig. 2A, left). This may indicate that the amount of NIRF
degraded in the ubiquitin-proteasome pathway is markedly
small in this condition as compared with the amount of over-
expressed NIRF.
Since many ubiquitin ligases are known to exhibit auto-
ubiquitination activity, we next examined whether NIRF is
capable of being auto-ubiquitinated in vitro, by employing
UbcH5a and UbcH7 as E2 ubiquitin conjugases expected to
cooperate with NIRF (Fig. 2B). On a Western blot, the ubiq-
uitinated NIRF was detected by anti-His antibody only in the
presence of E1, UbcH5a, and NIRF. Thus, NIRF is auto-
ubiquitinated in vitro in cooperation with UbcH5a but not
with UbcH7, in spite of conservation of the core domain
between both conjugases [18].
3.2. NIRF interacts with PCNP in vivo
We previously found, using a yeast two-hybrid system, a
glutathione S-transferase (GST) pull-down assay, and a mam-
malian two-hybrid assay, that both NIRF and PCNP were
located in the nucleus and associated with each other in
Fig. 1. Schematic representation of the domain composition of NIRF, ICBP90, and Parkin. UBL, ubiquitin-like domain [14]; PHD, plant ho-
meodomain ¢nger [23]; YDG/SRA, SET and RING ¢nger-associated domain containing a conserved motif YDG [24]; RING, RING ¢nger
[15]; IBR, in between RING ¢nger motif [16].
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vivo as well as in vitro [6]. As shown in Fig. 3, a co-immu-
noprecipitation assay further validated an in vivo interaction.
When extracts from COS-7 cells transfected with plasmids
encoding PCNP and/or FLAG-NIRF were subjected to im-
munoprecipitation by an anti-FLAG antibody followed by
Western blot analysis, PCNP was co-immunoprecipitated
with FLAG-NIRF (Fig. 3A), indicating at least that PCNP
and NIRF participate in the formation of the same supra-
molecular structure in vivo. And considering the previous re-
sults with two-hybrid systems and a GST pull-down assay [6],
PCNP and NIRF can directly interact with each other in the
complex. This was also ascertained by a reciprocal co-immu-
noprecipitation experiment, in which the cells were transfected
with FLAG-PCNP and/or myc-NIRF (Fig. 3B). Myc-
NIRF was co-immunoprecipitated with FLAG-PCNP by
anti-FLAG antibody. Moreover, the co-immunoprecipitated
myc-NIRF and FLAG-PCNP increased following treatment
with MG-132, suggesting that either NIRF or PCNP, or both
of them, were subject to ubiquitin-mediated degradation in
COS-7 cells. In view of the fact that PEST proteins are often
degraded via the ubiquitin-dependent pathway accompanied
by ubiquitin ligases [5,19], we then investigated whether
PCNP is susceptible to ubiquitination.
3.3. PCNP is readily ubiquitinated in vivo
In vivo ubiquitination of PCNP was examined by transfect-
ing the FLAG-ubiquitin (FLAG-Ub) construct into COS-7
cells followed by immunoprecipitation and Western blot
analysis (Fig. 4). In this system, a series of ubiquitinated
PCNP species with much higher molecular weights than
PCNP itself were easily detected. The ubiquitinated, en-
dogenous PCNPs were still observed without transfection.
Since PCNP is an abundant nuclear protein (data not shown),
a signi¢cant proportion of endogenous PCNP may be ubiq-
uitinated in COS-7 cells. Levels of ubiquitinated PCNP
increased markedly in PCNP-transfected cells, and further
increased following MG-132 treatment. As was expected
from the presence of high-score PEST sequences in PCNP
[6], these ¢ndings demonstrate that PCNP is readily ubiq-
uitinated in vivo and subsequently degraded by the protea-
some.
3.4. NIRF is capable of ubiquitinating PCNP
We next investigated whether the ubiquitin ligase activity of
NIRF could contribute to ubiquitination of PCNP. As noted
above, PCNP is ubiquitinated in COS-7 cells, but di¡erences
in the extent of PCNP ubiquitination were not clear between
COS-7 cells with and without NIRF co-transfection (data not
shown), possibly due to relatively higher endogenous ubiqui-
tin ligase activity. Therefore, we used 293 cells in order to
determine PCNP ubiquitination by NIRF. We transfected
PCNP with or without NIRF into 293 cells, and assessed
the formation of ubiquitinated PCNP (Fig. 5A). The signal
intensity was weak even for NIRF-transfected cells in the
Fig. 2. NIRF is ubiquitinated in vivo, and catalyzes an auto-ubiquitination reaction in vitro. A: 293 cells were transfected with 1 Wg of FLAG-
NIRF or mock vector. Twenty-four hours later the medium was changed, and the cells were further cultured for 12 h in the presence or ab-
sence of MG-132 (5 WM). Then, cell extracts were prepared and subjected to immunoprecipitation (IP) with anti-FLAG M2 a⁄nity gel, fol-
lowed by Western blot analysis (WB). The blot was immunostained with 0.5 Wg/ml of anti-FLAG antibody (left) or 1 Wg/ml of anti-ubiquitin
antibody (right). B: An in vitro ubiquitination reaction was performed as described in Section 2 with the indicated combinations of the puri¢ed
FLAG-NIRF, E1, and E2 (UbcH5a or UbcH7). The reaction mixture was subjected to SDS^PAGE, followed by Western blot analysis with
1 Wg/ml of anti-His antibody to visualize de novo conjugation of histidine-tagged ubiquitin [25].
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absence of MG-132 (lanes 2 and 3), probably owing to rapid
destruction of ubiquitinated PCNP in 293 cells. By the addi-
tion of MG-132, however, the signal intensity increased, and it
became clear that NIRF enhanced ubiquitination of PCNP
(lanes 4 and 5). In Fig. 5B, we analyzed the mono-ubiquiti-
nated form of PCNP. The amounts of mono-ubiquitinated
PCNP increased in the NIRF-transfected cells (Fig. 5B, lower
panel), and were proportional to the extents of PCNP ubiq-
uitination (see Fig. 5A). Thus, overexpressed NIRF was ca-
pable of ubiquitinating PCNP in vivo.
Again NIRF was co-immunoprecipitated with PCNP (Fig.
5B, upper panel), indicating that ubiquitination of PCNP oc-
curred in association with NIRF. While the amount of NIRF
co-immunoprecipitated with PCNP was less without MG-132
than with MG-132, this must be due to rapid degradation of
ubiquitinated PCNP in the absence of proteasome inhibitor.
In fact, the amounts of NIRF in the NIRF-transfected cell
extracts were practically equal with and without MG-132
(data not shown).
The capability of NIRF to be a ubiquitin ligase for PCNP
ubiquitination was also examined in vitro. Puri¢ed PCNP was
incubated in the ubiquitination mixture containing histidine-
tagged ubiquitin, and the ubiquitinated PCNPs were visual-
ized on Western blot with either anti-PCNP or anti-His anti-
body (Fig. 6). As shown in the ¢gure, PCNP was ubiquiti-
nated only in the presence of NIRF. Thus, NIRF as a
ubiquitin ligase is capable of ubiquitinating PCNP in vitro
as well as in vivo.
4. Discussion
4.1. NIRF family of proteins as possible ubiquitin ligases
NIRF and ICBP90 are moderately analogous to each other
in amino acid sequence (53% identical and 67% similar), and
counterparts of both have been found in mice, i.e. mouse
NIRF (GenBank accession number AB116653) and Np95
[7]. These four proteins share a characteristic domain con¢g-
uration, and constitute a novel family of nuclear proteins (Fig.
1) [9]. As noted above, NIRF is also structurally related to
Parkin, an RBR protein with ubiquitin ligase activity [16].
This similarity between NIRF and Parkin is seen in the do-
main composition, and both NIRF and Parkin exhibit ubiq-
uitin ligase activity, whereas they are not signi¢cantly similar
in their amino acid sequences. In this connection, ubiquitin
ligase activity can be a general functional property shared
among RING ¢nger proteins irrespective of divergences in
their entire structure [4,15]. Thus, all the members of the
NIRF family could be ubiquitin ligases with multi-domain
structures.
4.2. Multi-functionality of the NIRF family
To date, the NIRF family is considered to be cell prolifer-
ation-associated, and involved in tumorigenesis in various
ways. As to human NIRF, mRNA expression is high in the
proliferating phase but signi¢cantly low in the G0/G1 phase in
normal cells while it is consistently high in tumor cells. More-
over, the human NIRF gene maps to 9p24.1, just within a
Fig. 3. Assessment of the in vivo association of NIRF with PCNP. A: COS-7 cells were co-transfected with 0.5 Wg each of the plasmids encod-
ing PCNP (pCAGGS-PCNP) and FLAG-NIRF (p3UFLAG-NIRF) or the corresponding empty vectors (pCAGGS and p3UFLAG-CMV-10)
and cultured for 36 h. Cell extracts were prepared and immunoprecipitated with anti-FLAG M2 a⁄nity gel followed by Western blot analysis
with 0.5 Wg/ml of anti-FLAG monoclonal antibody (middle panel) or 2.5 Wg/ml of the a⁄nity-puri¢ed anti-PCNP polyclonal antibody [6] (low-
er panel). The cell extracts were also subjected to SDS^PAGE and immunostained with the anti-PCNP antibody (upper panel). B: COS-7 cells
were co-transfected with 0.5 Wg each of the plasmids encoding FLAG-PCNP (pFLAG-PCNP) and myc-NIRF (pCMV-Myc-NIRF) or the cor-
responding empty vectors (pFLAG-CMV-2 and pCMV-Myc). Twenty-four hours later the medium was changed, and cells were further cultured
for 12 h in the presence or absence of MG-132 (5 WM). Cell extracts were prepared and subjected to immunoprecipitation with anti-FLAG M2
a⁄nity gel followed by Western blot analysis with 0.5 Wg/ml of anti-FLAG antibody or 0.1 Wg/ml of anti-myc antibody (lower two panels).
The extracts were also subjected to SDS^PAGE and immunostained with these antibodies (upper two panels).
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small amplicon in some tumor cells [6], suggesting that the
NIRF gene could behave as an oncogene. In addition, the
¢nding that 9p24.1 is lost in various types of tumors at the
top of frequency (48%) has led to the prediction that an es-
sential tumor suppressor exists in this region [20]. NIRF is
involved in cell cycle control as a negative regulator (to be
published elsewhere). On the contrary, Np95/ICBP90 are pos-
itive regulators of cell proliferation [8^10]. Np95 is proposed
to be an oncogene candidate [10] and contributes to genome
stability in response to various genotoxic insults [11]. Taken
together, the NIRF family members may be ubiquitin ligases
contributing not only to cell cycle regulation but also to tu-
morigenesis.
4.3. Ubiquitination of PCNP by NIRF
The PEST hypothesis predicts that the proteins with ‘PEST
sequences’ tend to be degraded rapidly, often via the ubiqui-
tin-proteasome pathway [5]. In fact, many PEST proteins
have been de¢ned to be short-lived. Also they often act as
regulatory proteins [21,22]. We originally identi¢ed NIRF as
a partner interacting with PCNP in yeast two-hybrid screening
[6]. In this study, PCNP was ubiquitinated by NIRF both in
vivo and in vitro. This may imply that NIRF and PCNP may
be involved in the same signaling pathway concerned with cell
cycle regulation and/or genome stability.
Both cell cycle progression and genome stability are con-
trolled by an intricate network of signaling molecules includ-
ing ubiquitin ligases, transcription factors, and protein ki-
nases. NIRF could play a role in this network by
ubiquitinating certain substrates including PCNP, leading to
control of a signaling pathway for cellular homeostasis. The
Fig. 5. NIRF can ubiquitinate PCNP in vivo. A: 293 cells were co-transfected with 0.33 Wg each of the plasmids encoding FLAG-ubiquitin
(p3UFLAG-ubiquitin), PCNP (pCAGGS-PCNP) and NIRF (pCAGGS-NIRF) or the corresponding empty vectors (p3UFLAG-CMV-10 and
pCAGGS). Treatment of the cells with MG-132 and detection of ubiquitinated PCNP were done as described in the legend to Fig. 4. B: 293
cells were co-transfected with 0.33 Wg each of the plasmids encoding myc-ubiquitin (pCMV-Myc-ubiquitin), FLAG-PCNP (pFLAG-PCNP) and
HA-NIRF (pCMV-HA-NIRF) or the corresponding empty vectors (pCMV-Myc, pFLAG-CMV-2 and pCMV-HA). Treatment of the cells with
MG-132 was done as in A. Cell extracts were immunoprecipitated with anti-FLAG M2 a⁄nity gel followed by Western blot analysis with the
1:2000 diluted anti-HA antibody (upper panel) or 2.5 Wg/ml of the a⁄nity-puri¢ed anti-PCNP antibody (lower panel).
Fig. 4. PCNP is readily ubiquitinated in vivo. COS-7 cells were co-
transfected with 0.5 Wg each of the plasmids encoding FLAG-ubiq-
uitin (p3UFLAG-ubiquitin) and PCNP (pCAGGS-PCNP) or the
corresponding empty vectors (p3UFLAG-CMV-10 and pCAGGS).
Twenty-four hours later the medium was changed, and the cells
were further cultured for 12 h in the presence or absence of MG-
132 (5 WM). Cell extracts were prepared and subjected to immuno-
precipitation with 15 Wg/ml of the a⁄nity-puri¢ed anti-PCNP poly-
clonal antibody [6] followed by Western blot analysis with 0.5 Wg/ml
of anti-FLAG antibody.
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NIRF family of proteins could be subject to phosphorylation
[7], which may complicate their properties even further. In-
quiry into the network surrounding NIRF and PCNP will be
necessary.
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PAGE followed by Western blot analysis. The blots were probed
with 2.5 Wg/ml of the a⁄nity-puri¢ed anti-PCNP antibody (left) or
1 Wg/ml of the anti-His antibody (right).
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